Anti-CCR5 monoclonal antibody - Human Genome Sciences

Drug Profile

Anti-CCR5 monoclonal antibody - Human Genome Sciences

Alternative Names: HGS 1025

Latest Information Update: 21 Mar 2012

Price : $50

At a glance

  • Originator Human Genome Sciences
  • Class Monoclonal antibodies
  • Mechanism of Action CCR5 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Ulcerative colitis

Most Recent Events

  • 18 Jan 2012 Suspended - Phase-I clinical trials for Ulcerative colitis in USA (IV)
  • 09 Jan 2012 Discontinued - Phase-I for Ulcerative colitis in USA (IV)
  • 31 Dec 2010 Phase-I clinical trials in Ulcerative colitis in USA (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top